AI assistant
Aqua Bio Technology — Share Issue/Capital Change 2026
Feb 27, 2026
3535_dva_2026-02-27_282af94a-ea49-4586-a1b8-46a0443e2750.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Aqua Bio Technology ASA: Registration of share consolidation
Aqua Bio Technology ASA: Registration of share consolidation
Reference is made to the resolution by the general meeting of Aqua Bio
Technology ASA (the "Company") on 16 February 2026 regarding a share
consolidation (reverse share split) in the ratio 50:1, and the key information
notice regarding the share consolidation announced on 25 February 2026.
The share consolidation has today been registered with the Norwegian Register
of Business Enterprises. Following such registration, the share capital of the
Company is NOK 16,139,675 divided into 3,227,935 shares, each with a par value
of NOK 5.00.
Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA
Phone: +47 9509 2322
Email: [email protected]
About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.
This notice is published by Kristian Flaten on the listed date and time.
This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-02-27 12:55
CET.